Antiplatelet and Antithrombotics Drug Market Analysis in EU
$2,350.00 – $4,700.00
Type: Common Disease Area
Published : March 2021
Report ID : 553
Format: PPT, PDF
EU Antiplatelets and Antithrombotic Drug Market: Segmentation By Route Of Administration (Oral and parenteral) and By Therapy type (Apixaban, Dabigatran, Edoxaban, Fondaparinux, Heparin, Rivaroxaban)- Growth, Opportunities And Forecast (2019-2028)
The EU Antiplatelet and Antithrombotics Drug market reached a value of nearly $XX million in 2019 and the market is expected to grow to $XX million in 2028 with a CAGR of XX %
Antiplatelet drugs are often called as platelet agglutination inhibitor is a class of therapeutics that helps in reducing or preventing the blood coagulation by limiting the activity of platelets to stick or bind together. Clotting of blood is physiological action of the body which helps in controlling external bleeding during the time of injuries. Hence antiplatelet drug agents are therapeutically used to stop clotting as soon as possible. However, limitations in efficacy, safety, and tolerability of some antiplatelet drugs have precluded their use in patients. For instance, antiplatelet drugs can irritate the lining of the stomach that leads to gastrointestinal side effects such as indigestion and stomach aches. Moreover, patients using these drugs can be more prone to nosebleeds, bruising, or bleeding for longer than usual since they reduce the ability of the blood to clot. These factors are expected to hinder the growth of the antiplatelet drug market during the forecast period
Market Growth Drivers
The increasing cases of cardiac and cancer diseases in the EU is one of the factors which is expected to drive the overall anti-platelet and anti-thrombotic drug market. The significant growth in a market over a forecast period is mainly attributed due to hereditary diseases. The unavailability of alternatives for antithrombotic drugs coupled with the new product developments and launches are expected to bolster the market growth. Changing lifestyles and lack of physical activity is one of the factors which affects the growth of the market moderately during the forecast period. Failure to take antiplatelet drugs as prescribed can possess an increased risk of thrombotic complications, owing to rebound platelet activation. All these factors are expected to hinder the growth of the antiplatelet drug market during the forecast period
1. EU Anti-Platelet and Anti-Thrombotic Drug Market Overview…………..……. A. Market Size 2. Market Growth Drivers………………………………………….………..………………………………….. A. Increasing cases of hereditary, cardiac, and cancer diseases B. Changing lifestyle and growing physical inactivity C. Expanding new product developments and launches 3. EU Anti-Platelet and Anti-Thrombotic Drug Market Segmentation…………… A. By Route of Administration I. Oral Routes II. Parenteral Routes B. By Therapy Type I. Apixaban II. Dabigatran III. Edoxaban IV. Fondaparinux V. Heparin VI. Rivaroxaban 4. Anti-Platelet and Anti-Thrombotic Major Drug Market Share….………..….. A. Market Analysis, Insights and Forecast to 2028 by Revenue 5. Competitive Landscape……………………………………………………………………….……….. A. Major Players B. Products in Pipeline 6. Key Company Profiles………………………………………………………………….………………. A. Sanofi Pharmaceutical overview, Product & Services, Strategies & Financials B. Bristol-Myers Squibb company overview, Product & Services, Strategies & Financials C. CytosoSorbents company Corporation profile, Product & Services, Strategies & Financials 7. Healthcare Policies and Regulatory Landscape…………………………………….… A. Policy changes and Reimbursement scenario 8. Potential Growth Opportunities………………………………..……………………..………… A. Advancements in drug development 9. Factors Driving Future Growth……………………….………………………………………….. A. Key Industry Trends and Recent Developments in Anti-Platelet and Anti-Thrombotic Major Drug Market B. Future Opportunities 10. Conclusion
By Route of Administration:
The antiplatelet and anti-thrombotic drug market has been segmented into oral routes and parenteral routes. The parenteral route segment is expected to witness high growth during the forecast period, owing to the rapid onset of action shown by parenteral drugs
By Therapy Type:
There are different types of therapies available to treat Thrombosis. Blood thinners also known as anti-coagulants are the first-line therapy for thrombosis. These drugs are mainly used to break or dissolve the clot by showing enzymatic action. Apixaban, Dabigatran, Edoxaban, Fondaparinux, Heparin, and Rivaroxaban are the major drugs available in the EU market for treating Thrombosis
The major market players in the EU Antiplatelet and Antithrombotic drugs market include Sanofi, Bayer AG, Sanofi Boehringer Ingelheim GmbH, Genentech Inc., Bristol-Myers Squibb, Eli Lilly, Pfizer Inc. In 2020, CytoSorb was developed by Cytosorbents, which is the only approved therapy to remove ticagrelor in the EU and is intended to address a major unmet medical need of potentially life-threatening postoperative bleeding in cardiothoracic surgery patients on the drug. Antiplatelet drug, Eliquis has been a major growth driver for Bristol-Myers Squibb and partner Pfizer, as well as the overall biopharma sector
Insights10 will provide you reports within 10 key parameters which are:
Market growth drivers & restraints
Epidemiology or disease type
Key company profiles
Healthcare policies & regulatory framework
Factors driving future growth
Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Our analysis methodology involves three critical stages:
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Company Websites/Annual Reports
Published Research Reports
Press Releases of Key Market Players
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.
We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model. Two level validation is done and entails finalization of report scope and to way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)
Establishing market drivers and trends
Analyzing regulatory landscape to understand future growth
Market Segment based analysis to obtain revenue / volume
Analyzing current needs and determining penetration to estimate market
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to oﬀer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market. Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions. The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
Download Free Sample Report
Share with someone
Inquiry before buying
150+ Analyst and Consultants
Our team of 150+ analyst and consultants carry a rich experience working in Life sciences domain
Insights10 has 13000+ ready available syndicated market research reports
Specialised in Lifesciences Market
One stop solutions for all your Life-sciences market research requirements
This report addresses
Market intelligence to enable effective decision making
Growth opportunities and trend analysis
Historical data & forecasts
Speak to our analyst to know how this research was put together
Add more countries or regions as part of customisation
Understand how this report can have direct impact on your revenue